Carlos Romero
Mineola, NYNPI 1447228275
Payments from drug & device makers
$1,149,483in general payments, 2019–2025
Across 1,937 payments — averaging $593.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$768K
- Janssen Research & Development, LLC$341K
- Alnylam Pharmaceuticals Inc.$30K
- Merck$10K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1,711 | $768,035 |
| Janssen Research & Development, LLC | 16 | $341,295 |
| Alnylam Pharmaceuticals Inc. | 209 | $30,224 |
| Merck | 1 | $9,930 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.